S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   3,333.69 (-0.80%)
DOW   27,686.91 (-0.38%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   204.05 (-2.02%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   435.81 (-2.42%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,376.17 (-2.99%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   467.50 (-3.29%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:SMEDSharps Compliance Stock Price, Forecast & News

$8.32
-0.23 (-2.69 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.17
Now: $8.32
$8.69
50-Day Range
$5.83
MA: $6.93
$8.54
52-Week Range
$3.46
Now: $8.32
$8.99
Volume176,339 shs
Average Volume231,975 shs
Market Capitalization$136.07 million
P/E Ratio277.43
Dividend YieldN/A
Beta-0.67
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program. The company also provides Route-Based Pickup Service, a waste management service, which offers medical and hazardous waste pick-up services; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit and Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, government, consumers, and commercial markets, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is based in Houston, Texas.
Read More
Sharps Compliance logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Sanitary services
Sub-IndustryN/A
Current SymbolNASDAQ:SMED
CUSIPN/A
Phone713-432-0300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$44.31 million
Cash Flow$0.11 per share
Book Value$1.62 per share

Profitability

Net Income$210,000.00

Miscellaneous

Employees148
Market Cap$136.07 million
Next Earnings Date8/19/2020 (Confirmed)
OptionableOptionable
$8.32
-0.23 (-2.69 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SMED News and Ratings via Email

Sign-up to receive the latest news and ratings for SMED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sharps Compliance (NASDAQ:SMED) Frequently Asked Questions

How has Sharps Compliance's stock been impacted by Coronavirus?

Sharps Compliance's stock was trading at $5.38 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SMED shares have increased by 54.6% and is now trading at $8.32.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sharps Compliance?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sharps Compliance in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sharps Compliance
.

When is Sharps Compliance's next earnings date?

Sharps Compliance is scheduled to release its next quarterly earnings announcement on Wednesday, August 19th 2020.
View our earnings forecast for Sharps Compliance
.

How can I listen to Sharps Compliance's earnings call?

Sharps Compliance will be holding an earnings conference call on Wednesday, August 19th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Sharps Compliance's earnings last quarter?

Sharps Compliance Corp. (NASDAQ:SMED) posted its earnings results on Tuesday, April, 28th. The industrial products company reported ($0.10) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.06. The industrial products company earned $10.41 million during the quarter, compared to the consensus estimate of $10.64 million. Sharps Compliance had a net margin of 1.16% and a return on equity of 2.18%. During the same quarter in the previous year, the business earned ($0.07) EPS.
View Sharps Compliance's earnings history
.

What price target have analysts set for SMED?

3 brokers have issued 12-month target prices for Sharps Compliance's shares. Their forecasts range from $7.50 to $10.00. On average, they anticipate Sharps Compliance's stock price to reach $8.83 in the next year. This suggests a possible upside of 6.2% from the stock's current price.
View analysts' price targets for Sharps Compliance
.

Has Sharps Compliance been receiving favorable news coverage?

Media coverage about SMED stock has been trending neutral on Tuesday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sharps Compliance earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the industrial products company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about Sharps Compliance
.

Are investors shorting Sharps Compliance?

Sharps Compliance saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 56,000 shares, an increase of 202.7% from the January 31st total of 18,500 shares. Based on an average trading volume of 86,000 shares, the short-interest ratio is presently 0.7 days. Approximately 0.5% of the shares of the stock are short sold.
View Sharps Compliance's Short Interest
.

Who are some of Sharps Compliance's key competitors?

What other stocks do shareholders of Sharps Compliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sharps Compliance investors own include Alphabet (GOOG), Alibaba Group (BABA), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), NVIDIA (NVDA), Square (SQ), VBI Vaccines (VBIV), AbbVie (ABBV), Avid Technology (AVID) and Netflix (NFLX).

Who are Sharps Compliance's key executives?

Sharps Compliance's management team includes the following people:
  • Mr. David P. Tusa, CEO, Pres & Director (Age 59)
  • Ms. Diana Precht Diaz CPA, M.B.A., CPA, MBA, VP, CFO & Corp. Sec. (Age 56)
  • Mr. Gregory C. Davis, VP of Operations (Age 52)
  • Mr. Dennis P. Halligan, VP of Marketing (Age 45)
  • Ms. Linda Brock, VP of Sales

What is Sharps Compliance's stock symbol?

Sharps Compliance trades on the NASDAQ under the ticker symbol "SMED."

Who are Sharps Compliance's major shareholders?

Sharps Compliance's stock is owned by many different institutional and retail investors. Top institutional shareholders include Cadence Capital Management LLC (1.05%), UBS Group AG (0.57%), Lapides Asset Management LLC (0.53%), Ingalls & Snyder LLC (0.24%), Mackay Shields LLC (0.22%) and Wedge Capital Management L L P NC (0.11%). Company insiders that own Sharps Compliance stock include David P Tusa, Dennis Halligan, Diana P Diaz, Gregory C Davis and Parris H Holmes Jr.
View institutional ownership trends for Sharps Compliance
.

Which major investors are selling Sharps Compliance stock?

SMED stock was sold by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, Wedge Capital Management L L P NC, and Lapides Asset Management LLC. Company insiders that have sold Sharps Compliance company stock in the last year include David P Tusa, Dennis Halligan, Gregory C Davis, and Parris H Holmes Jr.
View insider buying and selling activity for Sharps Compliance
.

Which major investors are buying Sharps Compliance stock?

SMED stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Hancock Whitney Corp, New York State Common Retirement Fund, and Cadence Capital Management LLC. Company insiders that have bought Sharps Compliance stock in the last two years include David P Tusa, Diana P Diaz, and Parris H Holmes Jr.
View insider buying and selling activity for Sharps Compliance
.

How do I buy shares of Sharps Compliance?

Shares of SMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sharps Compliance's stock price today?

One share of SMED stock can currently be purchased for approximately $8.32.

How big of a company is Sharps Compliance?

Sharps Compliance has a market capitalization of $136.07 million and generates $44.31 million in revenue each year. The industrial products company earns $210,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. Sharps Compliance employs 148 workers across the globe.

What is Sharps Compliance's official website?

The official website for Sharps Compliance is www.sharpsinc.com.

How can I contact Sharps Compliance?

Sharps Compliance's mailing address is 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054. The industrial products company can be reached via phone at 713-432-0300 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.